相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Synthesis and anti-cancer activity of bis-amino-phosphine ligand and its ruthenium(II) complexes
Zelinda Engelbrecht et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)
A Comparison of the Toxicity of Mono, Bis, Tris and Tetrakis Phosphino Silver Complexes on SNO Esophageal Cancer Cells
Zelinda Engelbrecht et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2018)
The ability of silver(I) thiocyanate 4-methoxyphenyl phosphine to induce apoptotic cell death in esophageal cancer cells is correlated to mitochondrial perturbations
Zelinda Engelbrecht et al.
BIOMETALS (2018)
Anticancer activity of silver(I) cyclohexyldiphenylphosphine complexes toward SNO cancer cells
Kariska Potgieter et al.
JOURNAL OF COORDINATION CHEMISTRY (2017)
Apoptosis-inducing ability of silver(I) cyanide-phosphines useful for anti-cancer studies
Zelinda Human-Engelbrecht et al.
CYTOTECHNOLOGY (2017)
Synthesis of silver(I) p-substituted phenyl diphenyl phosphine complexes with the evaluation of the toxicity on a SNO cancer cell line
Kariska Potgieter et al.
INORGANICA CHIMICA ACTA (2016)
The effect of 1:2 Ag(I) thiocyanate complexes in MCF-7 breast cancer cells
Eloise Ferreira et al.
BIOMETALS (2015)
Synthesis and characterisation of silver(I) benzyldiphenylphosphine complexes: Towards the biological evaluation on SNO cells
Kariska Potgieter et al.
INORGANICA CHIMICA ACTA (2015)
SHELXT - Integrated space-group and crystal-structure determination
George M. Sheldrick
ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES (2015)
The induction of cell death by phosphine silver(I) thiocyanate complexes in SNO-esophageal cancer cells
Zelinda Human et al.
BIOMETALS (2015)
Silver(I) coordination complexes and extended networks assembled from S, Se, Te substituted acenaphthenes
Fergus R. Knight et al.
DALTON TRANSACTIONS (2013)
Anti-proliferative and anti-tumor activity of silver(I) compounds
Christina N. Banti et al.
METALLOMICS (2013)
Structural Properties, Cytotoxicity, and Anti-Inflammatory Activity of Silver(I) Complexes with tris(p-tolyl)Phosphine and 5-Chloro-2-Mercaptobenzothiazole
L. Kyros et al.
BIOINORGANIC CHEMISTRY AND APPLICATIONS (2010)
Novel Metals and Metal Complexes as Platforms for Cancer Therapy
Michael Frezza et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Inhibition of Tumor Proteasome Activity by Gold-Dithiocarbamato Complexes via Both Redox-Dependent and -Independent Processes
Xia Zhang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2010)
Organometallic compounds in oncology: implications of novel organotins as antitumor agents
Angela Alama et al.
DRUG DISCOVERY TODAY (2009)
Tetrameric 1:1 and monomeric 1:3 complexes of silver(I) halides with tri(p-tolyl)-phosphine: A structural and biological study
Sotiris Zartilas et al.
INORGANICA CHIMICA ACTA (2009)
New uses for old copper-binding drugs: converting the pro-angiogenic copper to a specific cancer cell death inducer
Di Chen et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2008)
Zinc as an anti-tumor agent in prostate cancer and in other cancers
Renty B. Franklin et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2007)
Trans-Platinum Complexes in Cancer Therapy
Mauro Coluccia et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2007)
Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity
Di Chen et al.
CANCER RESEARCH (2006)
From bench to bedside -: preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A)
Christian G. Hartinger et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2006)
Gold(III) dithiocarbamate derivatives for the treatment of cancer:: Solution chemistry, DNA binding, and hemolytic properties
L Ronconi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Ruthenium complexes as anticancer agents
I Kostova
CURRENT MEDICINAL CHEMISTRY (2006)
Platinum group antitumor chemistry: Design and development of new anticancer drugs complementary to cisplatin
AS Abu-Surrah et al.
CURRENT MEDICINAL CHEMISTRY (2006)
Cellular processing of platinum anticancer drugs
D Wang et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Gold dithiocarbamate derivatives as potential antineoplastic agents:: Design, spectroscopic properties, and in vitro antitumor activity
L Ronconi et al.
INORGANIC CHEMISTRY (2005)
Antitumor-active cobalt-alkyne complexes derived from acetylsalicylic acid: Studies on the mode of drug action
I Ott et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
A phase I and pharmacological study with imidazolium-trans-DMSO-imidazole-tetrachlororuthenate, a novel ruthenium anticancer agent
JM Rademaker-Lakhai et al.
CLINICAL CANCER RESEARCH (2004)
New organotropic compounds -: Synthesis, characterization and reactivity of Pt(II) and Au(III) complexes with bile acids:: DNA interactions and 'in vitro' anticancer activity
JJ Criado et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2003)
Gold(III) complexes with bipyridyl ligands: Solution chemistry, cytotoxicity, and DNA binding properties
G Marcon et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Gold(III) complexes as potential antitumor agents: Solution chemistry and cytotoxic properties of some selected gold(III) compounds
L Messori et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer
A de Gramont et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
分享论文
